Cite
APA Citation
Colombel, J. F., Panaccione, R., Nakase, H., Burmester, G., Cohen, S. B., Mease, P., Guttman-Yassky, E., Liu, J., Zhou, W., Ilo, D., & Higgins, P. (n.d.). p573 The safety profile of upadacitinib maintenance therapy in ulcerative colitis in the Phase 3 U-ACHIEVE study is consistent with that in approved indications. Journal of Crohn's and colitis, 16, i514. http://access.bl.uk/ark:/81055/vdc_100150514992.0x000018